Australia's Island Pharmaceuticals rises on US patent for dengue drug

Island Pharmaceuticals

11/12/2024 24:08

** Shares of Island Pharmaceuticals  ILA.AX  rise as much as
13.3% to A$0.170, their biggest intraday pct gain since Nov 27  
  
    ** The drug company says the United States Patent and
Trademark Office has granted a key patent for its drug ISLA-101 
    ** Patent covers a method of reducing severity of one or
more symptoms of dengue virus by administering ISLA-101 - co 
    ** ILA stock up 89.5% YTD, as of 1204 GMT

    
    
    

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))